These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23907370)

  • 1. Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results.
    van der Linden N; van Gils CW; Pescott CP; Buter J; Uyl-de Groot CA
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1673-8. PubMed ID: 23907370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.
    van der Linden N; van Gils CW; Pescott CP; Buter J; Vergeer MR; Groot CA
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2007-16. PubMed ID: 24943191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck.
    Okano S; Yoshino T; Fujii M; Onozawa Y; Kodaira T; Fujii H; Akimoto T; Ishikura S; Oguchi M; Zenda S; de Blas B; Tahara M; Beier F
    Jpn J Clin Oncol; 2013 May; 43(5):476-82. PubMed ID: 23479383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
    Heukelom J; Hamming O; Bartelink H; Hoebers F; Giralt J; Herlestam T; Verheij M; van den Brekel M; Vogel W; Slevin N; Deutsch E; Sonke JJ; Lambin P; Rasch C
    BMC Cancer; 2013 Feb; 13():84. PubMed ID: 23433435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Kwok Y; Goloubeva O; Parekh A; Taylor R; Wolf J; Zimrin A; Strome S; Ord R; Cullen KJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1845-50. PubMed ID: 21601372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
    Bonner JA; Giralt J; Harari PM; Baselga J; Spencer S; Bell D; Raben D; Liu J; Schulten J; Ang KK; Rosenthal DI
    Eur J Cancer; 2016 Sep; 64():1-11. PubMed ID: 27323346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies.
    Petrelli F; Coinu A; Riboldi V; Borgonovo K; Ghilardi M; Cabiddu M; Lonati V; Sarti E; Barni S
    Oral Oncol; 2014 Nov; 50(11):1041-8. PubMed ID: 25176576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin versus cetuximab given concurrently with definitive radiation therapy for locally advanced head and neck squamous cell carcinoma.
    Ley J; Mehan P; Wildes TM; Thorstad W; Gay HA; Michel L; Nussenbaum B; Trinkaus K; Adkins D
    Oncology; 2013; 85(5):290-6. PubMed ID: 24217231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concurrent simultaneous integrated boost radiotherapy and cetuximab in head and neck squamous cell cancer patients: is it feasible in daily clinical practice?].
    Chillari F; Parisi S; Ferrantelli G; Carrubba C; Santacaterina A; Critelli P; Sciacca M; Venuti V; Lillo S; Cacciola A; Iatì G; Pontoriero A; Platania A; Delia P; Tombolini V; De Felice F; Musio D; Spatola C; Brogna A; Pergolizzi S
    Recenti Prog Med; 2024 May; 115(5):1e-6e. PubMed ID: 38708539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
    León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
    Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH).
    Tao Y; Aupérin A; Sun X; Sire C; Martin L; Coutte A; Lafond C; Miroir J; Liem X; Rolland F; Even C; Nguyen F; Saada E; Maillard A; Colin-Batailhou N; Thariat J; Guigay J; Bourhis J
    Eur J Cancer; 2020 Dec; 141():21-29. PubMed ID: 33125944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.
    Levy AR; Johnston KM; Sambrook J; Donato B; Penrod JR; Corral M; Chasen M
    Curr Med Res Opin; 2011 Dec; 27(12):2253-9. PubMed ID: 22017232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.
    Rambeau A; Gervais R; De Raucourt D; Babin E; Dugué AE; Florescu C; Blanchard D; Gery B
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2883-2889. PubMed ID: 28382396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.
    Riaz N; Sherman E; Koutcher L; Shapiro L; Katabi N; Zhang Z; Shi W; Fury M; Wong R; Wolden S; Rao S; Lee N
    Am J Clin Oncol; 2016 Feb; 39(1):27-31. PubMed ID: 24401670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
    Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.
    Heron DE; Rwigema JC; Gibson MK; Burton SA; Quinn AE; Ferris RL
    Am J Clin Oncol; 2011 Apr; 34(2):165-72. PubMed ID: 20686406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region--a open labelled single arm phase II study.
    Dattatreya S; Goswami C
    Indian J Cancer; 2011; 48(2):154-7. PubMed ID: 21768658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.